Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4917.55%
operating margin TTM
-5121.76%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -2.79 |
| peg ratio | -0.10 |
| price to book ratio | 7.22 |
| price to sales ratio | 139.92 |
| enterprise value multiple | -2.63 |
| price fair value | 7.22 |
profitability ratios | |
|---|---|
| gross profit margin | -1082.7% |
| operating profit margin | -5121.76% |
| pretax profit margin | -4917.55% |
| net profit margin | -4917.55% |
| return on assets | -67.31% |
| return on equity | -188.82% |
| return on capital employed | -79.95% |
liquidity ratios | |
|---|---|
| current ratio | 3.80 |
| quick ratio | 3.80 |
| cash ratio | 1.77 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 94.29 |
| cash conversion cycle | -94.29 |
| receivables turnover | 0.00 |
| payables turnover | 3.87 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.39 |
| debt equity ratio | 1.49 |
| long term debt to capitalization | 0.58 |
| total debt to capitalization | 0.60 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -1.37 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.90 |
| cash per share | 0.77 |
| operating cash flow per share | -0.88 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.37 |
| short term coverage ratios | -18.30 |
| capital expenditure coverage ratio | -67.33 |
Frequently Asked Questions
When was the last time Prime Medicine, Inc. (NASDAQ:PRME) reported earnings?
Prime Medicine, Inc. (PRME) published its most recent earnings results on 07-05-2026.
What is Prime Medicine, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Prime Medicine, Inc. (NASDAQ:PRME)'s trailing twelve months ROE is -188.82%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Prime Medicine, Inc. (PRME) currently has a ROA of -67.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PRME's net profit margin stand at?
PRME reported a profit margin of -4917.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PRME's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.80 in the most recent quarter. The quick ratio stood at 3.80, with a Debt/Eq ratio of 1.49.